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REPLY 
Professor A. S. Breathnach, in his letter, raises some interestingly 
agreeable as well as controversial points of discussion which were, 
in our opinion, adequately discussed in our article published in 
the J Invest DermatoI 85(3) :222- 228, 1985. We carried out in vitro 
and in vivo studies to evaluate the selective melanocytotoxic and 
depigmenting property of azelaic acid (AZA) and to determine 
its value as a chemotherapeutic agent. O ur intent for these studies 
was to examine the effec ts of AZA on normal, proliferative, and 
m alignant melanocytes, at physiologic dose levels using the stan-
dard techniques of pigment cell research with which we have 
considerable experience. In black pigmented guinea pigs, the mel-
anocytotoxic effects of AZA , in terms of the inhibition of tyro-
sinase activity (dopa reaction), the melanocyte population, light 
and electron microscopic alterations in the morph ology of cells, 
and the clinical state of depigmentation, were compared w ith the 
known selective melanocytotoxic and depigmenting effects of 
po tent depigmenting agents such as 4-isopropylcatechol (4-IPC), 
4- hydroxyanisole (4-0 HA), hydroquinone (HQ), monobenzy-
lecher of hydroquinone (MBEHQ) , and monoethylether of hy-
droquinone (MEEHQ). AZA, even at 20% concentration, had 
little or no effect on proliferative melanocytes; contrary to this, 
4-IPC, 4-0 HA, MBEHQ, and MEEHQ were highly effective 
at 1 % concentration in inhibiting the growth of proliferative nor-
mal melanocytes. The effec t of AZA, as a chemotherapeutic agent, 
was evaluated in mice bearing subcutaneous B-1 6 melanoma tu-
m ors as well as mice bearing interperi toneally implanted B-1 6 
m elanoma tu inors. The in vivo effect of AZA on the growth and 
survival of S-91A (melanotic) and S-91 B (amelanotic) melanoma 
cells in culture was also examined. Our intentions were not to 
imply AZ A is not a benefi cial and therapeutic agent, especially 
for patients with lentigo maligna, but simply to demonstrate AZA 
at physiologic concentrations of 10- 5 to 10- 3 M does not exhibit 
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significant selective cytotoxic activity against pigmented no rmal 
melanocytes and against S-91 A (melanotic) and S-91 B (am elan_ 
otic) melan?ma cells. Importantly , significant in vivo inhibitory 
actIvIty aga1l1st transplantable tumor was not detected at diffe r en t 
concentrations. O ur data stand as published, and obviously t he 
comparison of results on di fferent species under different COn_ 
ditions does not appear to be valid , at leas t in the case of AZA. 
We agree the action mechanism of most melanocytotoxic agents 
may involve: (1) the di rect action on DNA synthesis involving 
S-phase toxicity; (2) an oxidant altering the oxidoreductase en_ 
zymes in energy-generating processes; (3) alterations on cellmern_ 
brane lipids and surfa ce permeability; or (4) indirect effects m e_ 
diated by the generation of reactive metaboli tes (e.g ., ·OH free_ 
radicals, semiquinones, and reactive oxygen species such as IO? 
Oi- , ·OOH, etc.). The free radi cals or reactive oxidation produc~~ 
of the depigmenting agent m ay affect the structural and fun ctional 
activity of cell membranes, mitochondria, or microsomes. It is 
probable that different mechanisms predominate different COrn_ 
pounds. The effects of AZA appear to be manifested at high 
concentrations exceedmg 10 - 3 M. The potent melanocytotox ic 
agents (e.g ., 4-IPC, 4-0HA, MBEHQ, and MEEHQ) not o nly 
inhibit DNA synthesis as a fun ction of concentration but also 
generate reactive free radi cals and oxygen species that affect the 
structural and fun ctional activity of cell membranes, mitochon_ 
dria, melanosomes, and microsomal enzymes at low concentra_ 
tions «10 - 3 M ) in both normal and I?roliferative abnormal m el_ 
anocytes . 
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Increase in Antigenicity of Basement Membrane Zone Antigens In Bullous 
Pemphigoid 
To the Editor: 
In a very interestin g article published in the July 1985 supplement 
iss ue [1], Jordon, Kawa na, and Fritz proposed the fo llowing 
mechanism of tissue injury in bullous pemphigoid : bullous pem-
ph igoid antigen in some way rendered immunogenic.to stimulate 
an antiself clone of B cell / plas ma cell s. 
Years ago we reported experiments demonstratin g that the 
action of proteolytic enzymes and galactosidases coul d expose 
hidden antigens of the basement membrane zone (BMZ) of the 
human skin that we called "activation of antigens" [2]. This was 
detected in the course of experim ents to delineate the antigenic 
structures of the antibody-binding sites for BMZ antibodies of 
pat ients with pemphigoid. Therefore, we stud ied the action of 
various enzymes in vitro, using the indirect immunoflu orescence 
method. We fo un d that a moderate expos ure of cryosta t sections 
of human skin to the ac tion of proteolytic enzy mes (papain and 
trypsin) and galactosidases increased antibody-binding capacity 
of the BMZ fo r BM Z antibodies , as demonstrated by an increased 
intensity of flu orescence of the BMZ and by an increase of titer-
dilution steps as compared with control sections not previously 
incubated [3). 
As regards the signifi cance of proteolytic enzy mes in the path-
ogenesis of bulla formation, Sti.i ttgen and Wiist [4] were able to 
demonstrate di- and tripeptidases regularly in blister fluid . A nd 
accordin g to studies o f B ra un-Falco [5], the action of trypsin and 
chymotrypsin on fresh, li ving skin res ults in separation of the 
epidermis and cutis and the histologic findin gs resemble those of 
bullous pemphigoid . 
Therefore, we have developed the hypothesis that a moderate 
action of pro teolyti c enzymes on BMZ antigens of the hu man 
skin markedl y increases the basement-membrane antibody-bind_ 
ing sites, indica ting an expos ure of hidden antigens. An increase 
in anti genicity could lead to the formation of autoantibodies of 
the basement-membrane antibody type [2,3,6). 
Furtherm ore, this mechanism-exposure of hidden antigens-
was shown in other experiments for the glomerular basement 
membrane too: Fillit et al (7) demonstra ted that patients with 
glomerul oneph ritis had a signifi cant blas togenic response to the 
glycosidase-trea ted glomerular basement membrane as compared 
with patients with nonglomerular renal discase and normal con-
trols. They suggested that removal of peripheral carbohyrate res-
